32 research outputs found
Using daptomycin for the treatment of surgical site infections in a single neurosurgical unit - preliminary experience
Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
In the present study we have performed both a meta-analysis and an analytical study exploring the presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii antibodies in a sample of 143 schizophrenic patients and 143 control subjects. The meta-analysis was performed on papers published up to April 2014. The presence of serum immunoglobulin G and immunoglobulin A was performed by enzyme-linked immunosorbent assay test. The detection of microbial DNA in total peripheral blood was performed by nested polymerase chain reaction. The meta-analysis showed that: 1) C. pneumoniae DNA in blood and brain are more common in schizophrenic patients; 2) there is association with parasitism by T. gondii, despite the existence of publication bias; and 3) herpes viruses were not more common in schizophrenic patients. In our sample only anti-Toxoplasma immunoglobulin G was more prevalent and may be a risk factor related to schizophrenia, with potential value for prevention.Part of this work was presented at the Royal Academy of Medicine of Spain
Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
Caracterización de Enterococcus faecium no sensible a daptomicina produciendo infección del tracto urinario en un paciente trasplantado renal
This work was supported only by the National Institute of
Allergy and Infectious Diseases (National Institutes of Health
[NIH] grant R01 AI093749 to C. A. A.)Objectives: Characterization of a urine isolate of daptomycin non-susceptible Enterococcus faecium recovered from a patient with kidney transplantation and no history of daptomycin exposure.
Methods: After isolation in a urine sample, identification of E. faecium was confirmed by amplification of the E. faecium-specific gene encoding D-alanyl-D-alanine ligase (ddl) and daptomycin susceptibility testing was performed by E-test on cation-adjusted Mueller-Hinton agar. In order to determine the genetic bases of daptomycin resistance, the open reading frames of five genes previously associated with daptomycin resistance in enterococci were sequenced.
Results: Substitutions in the response regulator LiaR (S19F) and cardiolipin synthase (R218Q) were identified.
Conclusions: To the best of our knowledge, this is the first characterization of emerging daptomycin resistance in E. faecium in a Spanish hospital in the absence of daptomycin exposure and in a renal transplant recipient.Objetivos. Presentamos la caracterización de un aislado
de Enterococcus faecium no sensible a daptomicina, recuperado de una muestra de orina de un paciente con trasplante de riñón e infección urinaria y sin antecedentes de exposición
previa a daptomicina.
Métodos. Tras el aislamiento, la identificación de E. faecium fue confirmada por la amplificación del gen que codifica
la región específica de la ligasa de la D-alanil-D-alanina (ddl)
y la prueba de sensibilidad a daptomicina se realizó mediante
E-test en agar Mueller-Hinton ajustado para cationes. Con el
fin de determinar las bases genéticas de la resistencia a daptomicina, se secuenciaron las regiones de lectura abierta de cinco
genes previamente asociados con la resistencia a daptomicina
en enterococos.
Resultados. Se identificaron cambios en el promotor de
LiaR (S19F) y la sintetasa de la cardiolipina (R218Q).
Conclusiones. Esta es la primera caracterización de un
aislado clínico de E. faecium con resistencia a daptomicina en
un hospital español, en ausencia de exposición previa y en un
receptor de trasplante renal.National Institutes of Health
[NIH] R01 AI09374
Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit
Glycopeptides and linezolid are the most widely used antibiotics to treat infections by methicillin-resistant Staphylococcus spp. We report the presence of various isolates of methicillin-resistant S. hominis subsp. hominis with resistance to linezolid and reduced susceptibility to glycopeptides. We studied ten blood culture isolates of S. hominis subsp. hominis from nine patients admitted to our hospital. Etest was used to study susceptibility to antibiotics commonly prescribed against staphylococci. Domain V region of the 23S rRNA gene was amplified and sequenced to detect possible mutations that confer resistance to linezolid. Pulsed-field gel electrophoresis (PFGE) was used for the clonality study of isolates. All isolates were resistant to oxacillin, gentamicin, levofloxacin, cotrimoxazole, and linezolid, and susceptible to tigecycline and daptomycin. Nine of the isolates were resistant to erythromycin and clindamycin, and showed heterogeneous resistance to glycopeptides. C2190T, G2603T, and G2474T mutations were detected in domain V of the 23S rRNA gene. PFGE showed the presence of two different clones. This report alerts to the possible appearance of clinical strains of methicillin-resistant staphylococci with intermediate resistance to glycopeptides, resistance to linezolid, and multiple resistance to other second-line antibiotics